| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 137, 479-488, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
RV Lloyd, K Fields, L Jin, E Horvath and K Kovacs
Department of Pathology, University of Michigan Medical Center, Ann Arbor 48109-0054.
The distribution of pro-opiomelanocortin (POMC) messenger RNA (mRNA) in 7 functional and 17 clinically silent corticotropic adenomas was analyzed by in situ hybridization (ISH) with 35S-labeled oligonucleotide probes using formalin-fixed paraffin-embedded tissue sections cut from blocks that were in storage between 1 to 14 years. All 7 functional adenomas and 4 subtype 1 tumors had detectable POMC mRNA, while 3 of 6 subtype 2 and 1 of 7 subtype 3 silent adenomas contained detectable POMC mRNA. In situ hybridization analysis with an 35S-labeled beta-actin probe showed a positive hybridization signal in 22 of 22 cases, indicating that the absence of detectable POMC mRNA in some adenomas was not due to loss of the mRNAs during processing of the tissues or because of the age of the embedded tissue blocks. Northern hybridization analysis with the oligonucleotide probes in 2 normal pituitaries and an adenoma causing Cushing's disease detected a 1.2-Kb mRNA in all three tissues, indicating that the oligonucleotide probes were very specific. These results indicate that subtype 1 silent adenomas and clinically active adenomas associated with Cushing's disease contain POMC mRNA that is readily detectable by ISH in routinely processed tissue specimens, while only a few of the subtypes 2 and 3 adenomas have POMC mRNA that can be detected in paraffin blocks with the oligonucleotide probes used in this study.
This article has been cited by other articles:
![]() |
R. C. Smallridge, K. Bourne, B. W. Pearson, J. A. van Heerden, P. C. Carpenter, and W. F. Young Cushing's Syndrome Due to Medullary Thyroid Carcinoma: Diagnosis by Proopiomelanocortin Messenger Ribonucleic Acid in Situ Hybridization J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4565 - 4568. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, X. Qian, E. Kulig, B. W. Scheithauer, R. Calle-Rodrigue, C. Abboud, D. H. Davis, K. Kovacs, and R. V. Lloyd Prolactin Receptor Messenger Ribonucleic Acid in Normal and Neoplastic Human Pituitary Tissues J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 963 - 968. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |